Search Within

Jedd D Wolchok

Formats
  1. Journal Article (450)
  2. Meeting Abstract (414)
  3. Book Section (19)
  4. Editorial (9)
  5. Review (5)
  6. Correspondence (3)
  7. Research Letter (3)
  8. Book Whole (1)
  9. Conference Paper (1)
Groups
  1. Department of Medicine (905)
  2. GSK Faculty (905)
  3. Melanoma and Immunotherapeutics Service (905)
  4. Solid Tumor Oncology Division (905)
  5. Melanoma Disease Management Team (222)
  6. Sloan Kettering Institute Postdocs (195)

More Groups

People
  1. Taha Merghoub (230)
  2. Michael Postow (158)
  3. Alan Houghton (118)
  4. Margaret Callahan (113)
  5. Paul Chapman (107)
  6. Katherine Panageas (92)

More People

Years
  1. 2024 (2)
  2. 2023 (15)
  3. 2022 (46)
  4. 2021 (42)
  5. 2020 (46)
  6. 2019 (47)

More Years

Publications
  1. Journal of Clinical Oncology (171)
  2. Journal for ImmunoTherapy of Cancer (81)
  3. Cancer Research (59)
  4. Clinical Cancer Research (35)
  5. Annals of Oncology (34)
  6. European Journal of Cancer (23)

More Publications

Publishers
  1. American Society of Clinical Oncology (171)
  2. American Association for Cancer Research (130)
  3. Biomed Central Ltd (83)
  4. Elsevier Inc. (72)
  5. Nature Publishing Group (52)
  6. Oxford University Press (44)

More Publishers

Results (905)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma
    Journal Article

    Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Rutkowski, P.; Lao, C. D.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
    Review

    Kraehenbuehl, L.; Weng, C. H.; Eghbali, S.; Wolchok, J. D.; Merghoub, T.
    Nature Reviews Clinical Oncology (2022)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; George, M.; Venkatesh, D.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Combining a novel dual RAF/MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Pharmacologic modulation of tumor glycolysis to improve responses to immune checkpoint blockade therapy
    Meeting Abstract

    Verma, S.; Maniyar, R.; Ko, M.; Budhu, S.; Serganova, I.; Zappasodi, R.; Blasberg, R.; Merghoub, T.; Wolchok, J.; Mangarin, L.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Single-cell RNA-seq reveals the critical roles of the sting- and MDA5-mediated cytosolic nucleic acid-sensing pathways as well as IFNAR/STAT2 signaling in recombinant MVA-induced antitumor immunity
    Meeting Abstract

    Liu, S.; Mazo, G.; Zhang, T.; Yang, N.; Wang, Y.; Tan, A.; Wang, J.; Choi, J.; Xiang, J. Z.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of stroma poor cancers
    Meeting Abstract

    Budhu, S.; Gupta, A.; Fitzgerald, K.; Giese, R.; Michel, A.; Holland, A.; Campesato, L. F.; Van Snick, J.; Uyttenhove, C.; Ritter, G.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • DREAMseq (Doublet Randomized Evaluation in Advanced Melanoma Sequencing): A phase III trial-ECOG-ACRIN EA6134
    Meeting Abstract

    Atkins, M. B.; Lee, S. J.; Chmielowski, B.; Ribas, A.; Tarhini, A. A.; Truong, T. G.; Davar, D.; O'Rourke, M. A.; Curti, B. D.; Brell, J. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save